Cargando…
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation
Autores principales: | Zwaveling-Soonawala, N., Hagebeuk, E. E., Slingerland, A. S., Ris-Stalpers, C., Vulsma, T., van Trotsenburg, A. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017308/ https://www.ncbi.nlm.nih.gov/pubmed/21109997 http://dx.doi.org/10.1007/s00125-010-1981-8 |
Ejemplares similares
-
Severe Developmental Delay, Epilepsy and Neonatal Diabetes (DEND) Syndrome: A Case Report*
por: Helmi, Muhd Alwi Muhd, et al.
Publicado: (2020) -
DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
por: Cho, Ja Hyang, et al.
Publicado: (2017) -
Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
por: Shah, Reshma P., et al.
Publicado: (2012) -
Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation
por: Mooij, Christiaan F., et al.
Publicado: (2021) -
Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
por: Boelen, Anita, et al.
Publicado: (2023)